Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 2
1942 1
1943 2
1944 2
1945 3
1946 7
1947 6
1948 4
1949 2
1950 4
1951 3
1952 5
1953 2
1954 9
1955 5
1956 5
1957 2
1958 3
1959 6
1960 6
1961 3
1962 1
1963 5
1964 10
1965 6
1966 4
1967 2
1968 1
1969 4
1970 3
1971 5
1972 5
1973 7
1974 7
1975 1
1976 3
1977 7
1978 3
1979 2
1980 2
1981 3
1982 3
1983 7
1984 3
1985 2
1986 1
1987 2
1988 4
1989 4
1990 6
1991 5
1992 5
1993 6
1994 3
1995 15
1996 8
1997 2
1998 8
1999 11
2000 8
2001 9
2002 13
2003 7
2004 5
2005 3
2006 3
2007 5
2008 8
2009 7
2010 9
2011 14
2012 9
2013 11
2014 18
2015 10
2016 7
2017 5
2018 5
2019 2
2020 4
2021 5
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

408 results
Results by year
Filters applied: . Clear all
Page 1
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
Furman RR, Sharman JP, Coutre SE, Cheson BD, Pagel JM, Hillmen P, Barrientos JC, Zelenetz AD, Kipps TJ, Flinn I, Ghia P, Eradat H, Ervin T, Lamanna N, Coiffier B, Pettitt AR, Ma S, Stilgenbauer S, Cramer P, Aiello M, Johnson DM, Miller LL, Li D, Jahn TM, Dansey RD, Hallek M, O'Brien SM. Furman RR, et al. Among authors: miller ll. N Engl J Med. 2014 Mar 13;370(11):997-1007. doi: 10.1056/NEJMoa1315226. Epub 2014 Jan 22. N Engl J Med. 2014. PMID: 24450857 Free PMC article. Clinical Trial.
PTC124 targets genetic disorders caused by nonsense mutations.
Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifillis P, Paushkin S, Patel M, Trotta CR, Hwang S, Wilde RG, Karp G, Takasugi J, Chen G, Jones S, Ren H, Moon YC, Corson D, Turpoff AA, Campbell JA, Conn MM, Khan A, Almstead NG, Hedrick J, Mollin A, Risher N, Weetall M, Yeh S, Branstrom AA, Colacino JM, Babiak J, Ju WD, Hirawat S, Northcutt VJ, Miller LL, Spatrick P, He F, Kawana M, Feng H, Jacobson A, Peltz SW, Sweeney HL. Welch EM, et al. Among authors: miller ll. Nature. 2007 May 3;447(7140):87-91. doi: 10.1038/nature05756. Epub 2007 Apr 22. Nature. 2007. PMID: 17450125
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.
Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A, Blum KA, Goy AH, Davies AJ, Zinzani PL, Dreyling M, Johnson D, Miller LL, Holes L, Li D, Dansey RD, Godfrey WR, Salles GA. Gopal AK, et al. Among authors: miller ll. N Engl J Med. 2014 Mar 13;370(11):1008-18. doi: 10.1056/NEJMoa1314583. Epub 2014 Jan 22. N Engl J Med. 2014. PMID: 24450858 Free PMC article. Clinical Trial.
Shade matching.
Miller LL. Miller LL. J Esthet Dent. 1993 Jul-Aug;5(4):143-53. doi: 10.1111/j.1708-8240.1993.tb00771.x. J Esthet Dent. 1993. PMID: 8037962 Review. No abstract available.
Pain in older adults.
Miller LL, Talerico KA. Miller LL, et al. Annu Rev Nurs Res. 2002;20:63-88. Annu Rev Nurs Res. 2002. PMID: 12092519 Review.
Educational outcomes associated with persistent speech disorder.
Wren Y, Pagnamenta E, Peters TJ, Emond A, Northstone K, Miller LL, Roulstone S. Wren Y, et al. Among authors: miller ll. Int J Lang Commun Disord. 2021 Mar;56(2):299-312. doi: 10.1111/1460-6984.12599. Epub 2021 Feb 2. Int J Lang Commun Disord. 2021. PMID: 33533175 Free PMC article.
In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax.
Martchenko Shilman M, Bartolo G, Alameh S, Peterson JW, Lawrence WS, Peel JE, Sivasubramani SK, Beasley DWC, Cote CK, Demons ST, Halasahoris SA, Miller LL, Klimko CP, Shoe JL, Fetterer DP, McComb R, Ho CC, Bradley KA, Hartmann S, Cheng LW, Chugunova M, Kao CY, Tran JK, Derbedrossian A, Zilbermintz L, Amali-Adekwu E, Levitin A, West J. Martchenko Shilman M, et al. Among authors: miller ll. ACS Infect Dis. 2021 Aug 13;7(8):2176-2191. doi: 10.1021/acsinfecdis.1c00190. Epub 2021 Jul 4. ACS Infect Dis. 2021. PMID: 34218660 Free PMC article.
408 results